Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor

Phase 1

Completed

• Conditions: Head and Neck Tumor

• Registration Number: NCT00406289
• Lead Sponsor: University Hospital, Ghent

Brief Summary

This study will evaluate the feasibility of higher and prolonged dose escalation concentrated in the intra-tumoral regions which are FDG-avid after two weeks of radiotherapy.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-11
• Study First Submitted: 2006-11-30
• Study First Submitted QC: 2006-11-30
• Study First Posted: 2006-12-04
• Primary Completion: 2009-08
• Study Completion: 2010-02
• Status Verified: 2010-09
• Last Update Submitted: 2010-09-03
• Last Update Posted: 2010-09-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

• Head and neck tumor
• Aged > 18 years

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Tumor recurrences

Trial Locations

Locations (1)

University Hospital Ghent; 🇧🇪 Ghent, Belgium